FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097568 [Registered on: 17/11/2025] Trial Registered Prospectively
Last Modified On: 17/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Hemoglobin Levels and Diabetic Retinopathy Severity in Type 2 Diabetes: A Cross-Sectional Study 
Scientific Title of Study   Association between haemoglobin levels and the severity of diabetic retinopathy in patients with type 2 diabetes mellitus 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR PRIYANK SONANI 
Designation  JUNIOR RESIDENT 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Department of Ophthalmology, Ground floor, AVBRH Building. Sawangi Meghe

Wardha
MAHARASHTRA
442001
India 
Phone  8460807577  
Fax    
Email  priyank0707@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR ARCHANA THOOL 
Designation  PROFESSOR 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Department of Ophthalmology, Ground floor, AVBRH Building. Sawangi Meghe

Wardha
MAHARASHTRA
442002
India 
Phone  8097497803  
Fax    
Email  drarchana8030@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR ARCHANA THOOL 
Designation  PROFESSOR 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Department of Ophthalmology, Ground floor, AVBRH Building. Sawangi Meghe

Wardha
MAHARASHTRA
442002
India 
Phone  8097497803  
Fax    
Email  drarchana8030@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Jawaharlal nehru medical college, Sawangi(Meghe), Wardha, Maharashtra 
Address  Jawaharlal nehru medical college, Sawangi(Meghe), Wardha, Maharashtra 442001 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR PRIYANK SONANI  Acharya Vinobha Bhave Rural Hospital  Department of Ophthalmology, Ground floor AVBRH building, Sawangi Meghe
Wardha
MAHARASHTRA 
8460807577

priyank0707@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instutional ethics committee, Datta Meghe Institute of higher education & research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E113||Type 2 diabetes mellitus with ophthalmic complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients above 18 years of age
Male/Female
Patients having different stages of diabetes retinopathy
Patient having type 2 diabetes mellitus
Participants who have reduced levels of haemoglobin
Participants who gave the informed consent 
 
ExclusionCriteria 
Details  Pregnant women
Patients with type 1 diabetes mellitus
Patients experiencing acute drops in hemoglobin levels due to bleeding
Patients with hemoglobinopathies.
Patients with malignancies.
Patients with other retinal pathologies
Patients with other systemic conditions affecting retina other than DM Type 2 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Association between haemoglobin concentration (g/dL) and severity of diabetic retinopathy (DR) at baseline  Single baseline assessment (at enrolment) 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The widespread metabolic disease known as type 2 diabetes mellitus (T2DM) is typified by both impaired insulin production and the incapacity of insulin-sensitive tissues to react to insulin as it should. One frequent microvascular condition that might lead to an avoidable cause of blindness is diabetic retinopathy (DR). To evaluate whether treatment methods should be modified, research is required to ascertain the prevalence of anaemia among diabetes patients. Anaemia has been linked to the development of DR and is a frequent complication in persons with type 2 diabetes.

Aim of the study 

To know the association between Hemoglobin levels and the severity of Diabetic Retinopathy in patients with type 2 Diabetes Mellitus


 
Close